RCM
PYXS icon

RA Capital Management’s Pyxis Oncology PYXS Stock Holding History

RA Capital Management’s Portfolio PYXS Stock Details PYXS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-764,653
Closed -$1.51M – 77
2022
Q3 		$1.51M Sell
764,653
-188,740
-20% -$493K 0.03% 77
2022
Q2 		$2.27M Sell
953,393
-1,328,780
-58% -$3.54M 0.06% 79
2022
Q1 		$9.22M Hold
2,282,173
– – 0.2% 80
2021
Q4 		$25M Buy
+2,282,173
New +$26.1M 0.44% 56

Other funds holding PYXS

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return

RA Capital Management's PYXS Position: Q4 2022 in Review

RA Capital Management sold out of Pyxis Oncology (PYXS) in Q4 2022, closing a stake of 764,653 shares — an estimated $1.51M sold.

RA Capital Management first reported a position in PYXS in Q4 2021 and held it in 4 quarters. The position peaked at $25M in Q4 2021. 31 funds tracked by Wall St. Rank hold PYXS as of Q4 2022.

  • RA Capital Management reported no remaining Pyxis Oncology position as of Q4 2022 after selling out during the quarter.
  • RA Capital Management sold 764,653 Pyxis Oncology shares in Q4 2022, an estimated $1.51M.
  • RA Capital Management first reported a position in Pyxis Oncology in Q4 2021 and held it in 4 quarters.
  • RA Capital Management's Pyxis Oncology position peaked at $25M in Q4 2021.
  • 31 funds tracked by Wall St. Rank held Pyxis Oncology as of Q4 2022.

Based on RA Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.